Pages
(Move to ...)
Home
Our Purpose
Leadership
Other Links
▼
Sunday, December 12, 2010
Study Of Novartis Drug Zometa For Potential New Use In Early Breast Cancer Did Not Meet Primary Endpoint In Overall Study Population
Study Of Novartis Drug Zometa For Potential New Use In Early Breast Cancer Did Not Meet Primary Endpoint In Overall Study Population
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment